eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | autosomal dominant polycystic kidney disease |
| Comorbidity | C0035078|renal failure |
| Sentences | 8 |
| PubMedID- 20821268 | A 60 year old woman with end-stage renal failure due to autosomal dominant polycystic kidney disease (adpkd) underwent renal transplantation. |
| PubMedID- 22293308 | autosomal dominant polycystic kidney disease (adpkd) is primarily associated with renal failure, but it also causes systemic diseases, including cysts of other systemic organs and cerebral or visceral aneurysm. |
| PubMedID- 23110033 | The authors suggested that there is no clear evidence for an association between rcc and chronic renal failure in patients with adpkd.11 however, rcc has recently been found in patients with adpkd and chronic renal failure in a large population-based study. |
| PubMedID- 23105924 | Five percent of all cases of chronic renal failure are due to adpkd, and approximately 50% of adpkd patients will develop end-stage renal disease by the time they are 60 years of age [1]. |
| PubMedID- 21964037 | [slow the pace of renal failure in autosomal dominant polycystic kidney disease: hopes and disappointments]. |
| PubMedID- 22902029 | Purpose: cyst proliferation in patients with autosomal dominant polycystic kidney disease is associated with renal failure, hypertension and pain. |
| PubMedID- 21518865 | Mutations in polycystin-1 (pc1) lead to autosomal-dominant polycystic kidney disease (adpkd), a leading cause of renal failure for which no treatment is available. |
| PubMedID- 20139063 | Background: autosomal dominant polycystic kidney disease (adpkd), a major cause of end-stage renal failure, results from genetic mutation of either polycystin-1 (pkd1) or polycystin-2 (pkd2). |
Page: 1